Stockreport

Prevail Therapeutics Provides PR001 Program Update

Prevail Therapeutics Inc.  (PRVL) 
Last prevail therapeutics inc. earnings: 11/12 09:30 am Check Earnings Report
PDF PR001 Administered to International Type 2 Gaucher Disease Patient Via Compassionate Use Pathway Company Advancing its Phase 1/2 Clinical Trial for the Treatment of Neu [Read more]